Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Maintenance × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 8 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Plasma Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Chromosome 17 deletion 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡